{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:16:07Z","timestamp":1784765767787,"version":"3.55.0"},"reference-count":43,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Silesia, Poland","award":["KNW\u20101\u2010076\/K\/6\/0"],"award-info":[{"award-number":["KNW\u20101\u2010076\/K\/6\/0"]}]},{"DOI":"10.13039\/501100004442","name":"National Science Centre, Poland","doi-asserted-by":"publisher","award":["DEC\u20102017\/01\/X\/NZ5\/00114"],"award-info":[{"award-number":["DEC\u20102017\/01\/X\/NZ5\/00114"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The strong association between diabetes mellitus type 2 and cancer is observed. The incidence of both diseases is increasing globally due to the interaction between them. Recent studies suggest that there is also an association between cancer incidence and anti-diabetic medications. An inhibitor of dipeptidyl-peptidase 4 (DPP-4), sitagliptin, is used in diabetes treatment. We examined the influence of sitagliptin alone or in combination with a cytostatic drug (paclitaxel) on the development of epithelial ovarian cancer cells and the process of metastasis. We examined migration, invasiveness, apoptosis, and metalloproteinases (MMPs) and their inhibitors\u2019 (TIMPs) production in two human ovarian cancer cell lines. Sitagliptin induced apoptosis by caspase 3\/7 activation in paclitaxel-treated SKOV-3 and OVCAR-3 cells. Sitagliptin maintained paclitaxel influence on ERK and Akt signaling pathways. Sitagliptin additionally reduced migration and invasiveness of SKOV-3 cells. There were distinct differences of metalloproteinases production in sitagliptin-stimulated ovarian cancer cells in both cell lines, despite their identical histological classification. Only the SKOV-3 cell line expressed MMPs and TIMPs. SKOV-3 cells co-treated with sitagliptin and paclitaxel decreased concentrations of MMP-1, MMP-2, MMP-7, MMP-10, TIMP-1, TIMP-2. The obtained data showed that sitagliptin used with paclitaxel may be considered as a possibility of pharmacological modulation of intracellular transmission pathways to improve the response to chemotherapy.<\/jats:p>","DOI":"10.3390\/ijms21238976","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T09:04:15Z","timestamp":1606381455000},"page":"8976","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Sitagliptin Modulates the Response of Ovarian Cancer Cells to Chemotherapeutic Agents"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6767-9586","authenticated-orcid":false,"given":"Agnieszka","family":"Kosowska","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5343-1205","authenticated-orcid":false,"given":"Wojciech","family":"Garczorz","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"K\u0142ych-Ratuszny","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza F.","family":"Aghdam","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Kimsa-Furdzik","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Simka-Lampa","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6321-6090","authenticated-orcid":false,"given":"Tomasz","family":"Francuz","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Medyk\u00f3w 18, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.diabres.2017.04.005","article-title":"Diabetes mellitus and risk of ovarian cancer. A systematic review and meta-analysis of 15 cohort studies","volume":"130","author":"Zhang","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(14)60886-2","article-title":"The global implications of diabetes and cancer","volume":"383","author":"Shi","year":"2014","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/iub.1709","article-title":"Significance of circulatory DPP4 activity in metabolic diseases","volume":"70","author":"Nargis","year":"2018","journal-title":"IUBMB Life"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40265-016-0686-9","article-title":"Sitagliptin: A review in type 2 diabetes","volume":"77","author":"Prakash","year":"2017","journal-title":"Drugs"},{"key":"ref_5","first-page":"FC14","article-title":"Evaluation of anti cancer effects of D PP-4 inhibitors in colon cancer-An in vitro study","volume":"9","author":"Amritha","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejps.2016.12.040","article-title":"Sitagliptin inhibit human lymphocytes proliferation and Th1\/Th17 differentiation in vitro","volume":"100","author":"Pinheiro","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.amjmed.2009.12.007","article-title":"Incretin-based therapies: Review of current clinical trial data","volume":"123","author":"Peters","year":"2010","journal-title":"Am. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1210\/jc.2012-1544","article-title":"Sitagliptin exerts an anti-inflammatory action","volume":"97","author":"Makdissi","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2011.12.418","article-title":"Carcinosarcoma of the ovary: A review of the literature","volume":"125","author":"Birrer","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_10","first-page":"9","article-title":"Histological classification of ovarian cancer","volume":"36","author":"Kaku","year":"2003","journal-title":"Med. Mol. Morphol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10585-008-9171-5","article-title":"Phenotypic plasticity of neoplastic ovarian epithelium: Unique cadherin profiles in tumor progression","volume":"25","author":"Hudson","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djg036","article-title":"A randomized clinical trial of Cisplatin\/Paclitaxel versus Carboplatin\/Paclitaxel as first-line treatment of ovarian cancer","volume":"95","author":"Meier","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clon.2014.10.001","article-title":"Dose-dense Paclitaxel in advanced ovarian cancer","volume":"27","author":"Kumar","year":"2015","journal-title":"Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1158\/0008-5472.CAN-14-3098","article-title":"Chemotherapy induces programmed cell death-ligand 1 overexpression via the nuclear factor-b to foster an immunosuppressive tumor microenvironment in ovarian cancer","volume":"75","author":"Peng","year":"2015","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fonc.2018.00341","article-title":"Metformin as a therapeutic target in endometrial cancers","volume":"8","author":"Lee","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_16","first-page":"114","article-title":"Matrix metalloproteinases and their inhibitors. The role in the development of diabetic microangiopathy","volume":"1","author":"Kosowska","year":"2012","journal-title":"Diabet. Klin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pharep.2017.10.003","article-title":"Exenatide modulates metalloproteinase expression in human cardiac smooth muscle cells via the inhibition of Akt signaling pathway","volume":"70","author":"Kosowska","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejca.2015.12.016","article-title":"Targeting the tumour microenvironment in ovarian cancer","volume":"56","author":"Hansen","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-016-0740-2","article-title":"Tumor-associated stromal cells as key contributors to the tumor microenvironment","volume":"18","author":"Bussard","year":"2016","journal-title":"Breast Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: Alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ygyno.2015.06.003","article-title":"Immunological changes in the ascites of cancer patients after intraperitoneal administration of the bispecific antibody catumaxomab (anti-EpCAM \u00d7 anti-CD3)","volume":"138","author":"Fossati","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2016.04.038","article-title":"Tumor microenvironment: The culprit for ovarian cancer metastasis?","volume":"377","author":"Luo","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1530\/EC-17-0294","article-title":"Exenatide modulates tumor\u2013endothelial cell interactions in human ovarian cancer cells","volume":"6","author":"Kosowska","year":"2017","journal-title":"Endocr. Connect."},{"key":"ref_24","first-page":"386","article-title":"DPP4 in diabetes","volume":"6","author":"Wronkowitz","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-0042-100910","article-title":"Diabetes and cancer: A review of current knowledge","volume":"124","author":"Wojciechowska","year":"2016","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07435800.2017.1292525","article-title":"Exendin-4 does not modify growth or apoptosis of human colon cancer cells","volume":"86","author":"Wenjing","year":"2017","journal-title":"Endocr. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/14737140.2017.1398088","article-title":"Optimizing treatment in recurrent epithelial ovarian cancer","volume":"17","author":"Corrado","year":"2017","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1200\/JCO.2016.67.4044","article-title":"Type 2 diabetes mellitus and cancer: The role of pharmacotherapy","volume":"34","author":"Shlomai","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1007\/s10637-020-00920-7","article-title":"Phase I study of metformin in combination with carboplatin\/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer","volume":"38","author":"Broekman","year":"2020","journal-title":"Investig. New Drugs"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1177\/1933719113488441","article-title":"Metformin, at concentrations corresponding to the treatment of diabetes, potentiates the cytotoxic effects of Carboplatin in cultures of ovarian cancer cells","volume":"20","author":"Erices","year":"2013","journal-title":"Reprod. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Du, J., Shi, H., Ren, F., Wang, J.-L., Wu, Q., Li, X., and Zhang, R. (2017). Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3840-1"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.12659\/MSM.909745","article-title":"Anticancer activity of metformin, an antidiabetic drug, against ovarian cancer cells involves inhibition of Cysteine-Rich 61 (Cyr61)\/Akt\/mammalian target of Rapamycin (mTOR) signaling pathway","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"109439","DOI":"10.1016\/j.cellsig.2019.109439","article-title":"Betacellulin enhances ovarian cancer cell migration by up-regulating Connexin43 via MEK-ERK signaling","volume":"65","author":"Zhao","year":"2020","journal-title":"Cell. Signal."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/PAS.0000000000000476","article-title":"Morphologic and molecular characteristics of mixed epithelial ovarian cancers","volume":"39","author":"MacKenzie","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_35","first-page":"41","article-title":"Ovarian cancer: A heterogeneous disease","volume":"85","author":"Leary","year":"2017","journal-title":"Pathobiology"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Garziera, M., Roncato, R., Montico, M., De Mattia, E., Gagno, S., Poletto, E., Scalone, S., Canzonieri, V., Giorda, G., and Sorio, R. (2019). New challenges in tumor mutation heterogeneity in advanced ovarian cancer by a targeted Next-Generation Sequencing (NGS) approach. Cells, 8.","DOI":"10.3390\/cells8060584"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/GCO.0000000000000516","article-title":"Single-cell sequencing in ovarian cancer","volume":"31","author":"Winterhoff","year":"2019","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1158\/1078-0432.CCR-05-2338","article-title":"The Clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer","volume":"12","author":"Kamat","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrc3341","article-title":"The influence of race and ethnicity on the biology of cancer","volume":"12","author":"Henderson","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_40","unstructured":"Justus, C.R., Leffler, N., Ruiz-Echevarria, M., and Yang, L.V. (2014). In vitro cell migration and invasion assays. J. Vis. Exp., e51046."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ceb.2005.08.002","article-title":"Cell migration in tumors","volume":"17","author":"Yamaguchi","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/17460441.2018.1426567","article-title":"The latest animal models of ovarian cancer for novel drug discovery","volume":"13","author":"Magnotti","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1158\/1535-7163.MCT-07-2199","article-title":"Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9","volume":"7","author":"Lin","year":"2008","journal-title":"Mol. Cancer Ther."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/23\/8976\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:37:41Z","timestamp":1760179061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/23\/8976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":43,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["ijms21238976"],"URL":"https:\/\/doi.org\/10.3390\/ijms21238976","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,26]]}}}